15 February 2021 Priya Vaidya 3132 Case Updates Neurim Pharmaceuticals v Generics UK Limited [2020] EWHC 3270 (Pat) by Priya Vaidya The case: A patent case relating to prolonged release pharmaceutical formulations in which the active ingredient melatonin is intended to improve the restorative quality of sleep in a patient suffering from primary insomnia characterised by non-restorative sleep. The case called for experts in sleep medicine. To continue reading you must be an EWI member, become a member and access exclusive content. Already a member? Login Share Print Tags Bias06. Rules and Regulations11. Report Writing Related articles The mandatory duty on range of opinion Scottish Medicolegal Conference 2026 Categorisation of injuries for sentencing purposes Psychologists and general practitioner records Blackpool Borough Council v RR [2026] EWFC 69 Switch article R (IJ (Kosovo)) v Secretary of State for the Home Department [2020] EWHC 3487 (Admin) Previous Article B v A [2020] EWHC 3138 (Fam) Next Article Comments are only visible to subscribers.